Brief: Nykode Therapeutics CEO Acquires 6,000 Shares In Co
Feb 29 (Reuters) - Nykode Therapeutics ASA NYKD.OL :
* PRIMARY INSIDER MICHAEL ENGSIG, CHIEF EXECUTIVE OFFICER OF
NYKODE THERAPEUTICS ASA, HAS TODAY ACQUIRED 6,000 SHARES IN
NYKODE THERAPEUTICS ASA AT A PRICE OF NOK 16.71 PER SHARE
* FOLLOWING TRANSACTION, MICHAEL ENGSIG HOLDS 15,850 SHARES
IN
NYKODE THERAPEUTICS ASA
Source text for Eikon: ID:nObifDWFKa
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026